BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

866 related articles for article (PubMed ID: 22553001)

  • 1. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
    Oerlemans MI; Liu J; Arslan F; den Ouden K; van Middelaar BJ; Doevendans PA; Sluijter JP
    Basic Res Cardiol; 2012 Jul; 107(4):270. PubMed ID: 22553001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necrostatin-1 alleviates reperfusion injury following acute myocardial infarction in pigs.
    Koudstaal S; Oerlemans MI; Van der Spoel TI; Janssen AW; Hoefer IE; Doevendans PA; Sluijter JP; Chamuleau SA
    Eur J Clin Invest; 2015 Feb; 45(2):150-9. PubMed ID: 25496079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
    Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of programmed necrosis limits infarct size through altered mitochondrial and immune responses in the aged female rat heart.
    Garvin AM; Jackson MA; Korzick DH
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1434-H1442. PubMed ID: 29957016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction.
    Hwa JS; Jin YC; Lee YS; Ko YS; Kim YM; Shi LY; Kim HJ; Lee JH; Ngoc TM; Bae KH; Kim YS; Chang KC
    J Ethnopharmacol; 2012 Jan; 139(2):605-15. PubMed ID: 22179023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrostatin-1 Protects Against Paraquat-Induced Cardiac Contractile Dysfunction via RIP1-RIP3-MLKL-Dependent Necroptosis Pathway.
    Zhang L; Feng Q; Wang T
    Cardiovasc Toxicol; 2018 Aug; 18(4):346-355. PubMed ID: 29299822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.
    Montecucco F; Lenglet S; Braunersreuther V; Pelli G; Pellieux C; Montessuit C; Lerch R; Deruaz M; Proudfoot AE; Mach F
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1371-7. PubMed ID: 20413731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrostatin-1 inhibits Hmgb1-IL-23/IL-17 pathway and attenuates cardiac ischemia reperfusion injury.
    Zhang A; Mao X; Li L; Tong Y; Huang Y; Lan Y; Jiang H
    Transpl Int; 2014 Oct; 27(10):1077-85. PubMed ID: 24810904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium 4-Phenylbutyrate Attenuates Myocardial Reperfusion Injury by Reducing the Unfolded Protein Response.
    Takatori O; Usui S; Okajima M; Kaneko S; Ootsuji H; Takashima SI; Kobayashi D; Murai H; Furusho H; Takamura M
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):283-292. PubMed ID: 27909014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of myocardial injury and collagen deposition following ischaemia-reperfusion by linagliptin and liraglutide, and both together.
    Wang X; Ding Z; Yang F; Dai Y; Chen P; Theus S; Singh S; Budhiraja M; Mehta JL
    Clin Sci (Lond); 2016 Aug; 130(15):1353-62. PubMed ID: 27129181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
    Sánchez JA; Rodríguez-Sinovas A; Barba I; Miró-Casas E; Fernández-Sanz C; Ruiz-Meana M; Alburquerque-Béjar JJ; García-Dorado D
    Basic Res Cardiol; 2013 May; 108(3):351. PubMed ID: 23595215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
    Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion.
    Montecucco F; Lenglet S; Braunersreuther V; Burger F; Pelli G; Bertolotto M; Mach F; Steffens S
    J Mol Cell Cardiol; 2009 May; 46(5):612-20. PubMed ID: 19162037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury.
    Koshinuma S; Miyamae M; Kaneda K; Kotani J; Figueredo VM
    J Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24113863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
    Arslan F; Smeets MB; O'Neill LA; Keogh B; McGuirk P; Timmers L; Tersteeg C; Hoefer IE; Doevendans PA; Pasterkamp G; de Kleijn DP
    Circulation; 2010 Jan; 121(1):80-90. PubMed ID: 20026776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIP1-dependent and independent effects of necrostatin-1 in necrosis and T cell activation.
    Cho Y; McQuade T; Zhang H; Zhang J; Chan FK
    PLoS One; 2011; 6(8):e23209. PubMed ID: 21853090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart.
    Obana M; Miyamoto K; Murasawa S; Iwakura T; Hayama A; Yamashita T; Shiragaki M; Kumagai S; Miyawaki A; Takewaki K; Matsumiya G; Maeda M; Yoshiyama M; Nakayama H; Fujio Y
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H569-77. PubMed ID: 22707562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-α in cardiac ischaemia/reperfusion injury.
    Cabrera-Fuentes HA; Ruiz-Meana M; Simsekyilmaz S; Kostin S; Inserte J; Saffarzadeh M; Galuska SP; Vijayan V; Barba I; Barreto G; Fischer S; Lochnit G; Ilinskaya ON; Baumgart-Vogt E; Böning A; Lecour S; Hausenloy DJ; Liehn EA; Garcia-Dorado D; Schlüter KD; Preissner KT
    Thromb Haemost; 2014 Dec; 112(6):1110-9. PubMed ID: 25354936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of receptor-interacting protein 3 upregulation and nuclear translocation involved in Necrostatin-1 protection against hippocampal neuronal programmed necrosis induced by ischemia/reperfusion injury.
    Yin B; Xu Y; Wei RL; He F; Luo BY; Wang JY
    Brain Res; 2015 Jun; 1609():63-71. PubMed ID: 25801119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.